In humans, women diagnosed with GDM have significantly lower plasma kisspeptin when compared to normoglycaemic healthy controls, identifying kisspeptin as a potential biomarker for the clinical diagnosis of GDM (Bowe et al. 2019). Here, KISS1 is linked to gestational diabetes.